Tilelizumab
BCLC Stage C Hepatocellular Carcinoma
First Affiliated Hospital of Zhejiang UniversityPhase 2
—
Rating in progress
Tilelizumab in BCLC Stage C Hepatocellular Carcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active